The subsequent two-step MR mediation analyses demonstrated that the protective effect of anilides on liver cancer risk is partially mediated by increased immunophenotypes of CD3 on naive CD8+ T cells and CD3 on naive CD4+ T cells. The gene discussed is CD8A; the disease is liver cancer.